{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T15:17:45Z","timestamp":1791213465672,"version":"4.1.0"},"reference-count":56,"publisher":"Public Library of Science (PLoS)","issue":"6","license":[{"start":{"date-parts":[[2012,6,4]],"date-time":"2012-06-04T00:00:00Z","timestamp":1338768000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0038013","type":"journal-article","created":{"date-parts":[[2012,6,5]],"date-time":"2012-06-05T07:30:21Z","timestamp":1338881421000},"page":"e38013","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":47,"title":["In Vivo Human Apolipoprotein E Isoform Fractional Turnover Rates in the CNS"],"prefix":"10.1371","volume":"7","author":[{"given":"Kristin R.","family":"Wildsmith","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacob M.","family":"Basak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruce W.","family":"Patterson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuriy","family":"Pyatkivskyy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jungsu","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kevin E.","family":"Yarasheski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer X.","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kwasi G.","family":"Mawuenyega","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hong","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maia","family":"Parsadanian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hyejin","family":"Yoon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tom","family":"Kasten","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wendy C.","family":"Sigurdson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chengjie","family":"Xiong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alison","family":"Goate","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David M.","family":"Holtzman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Randall J.","family":"Bateman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2012,6,4]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1146\/annurev.genom.1.1.507","article-title":"Apolipoprotein E: far more than a lipid transport protein.","volume":"1","author":"RW Mahley","year":"2000","journal-title":"Annu Rev Genomics Hum Genet"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1016\/j.tibs.2006.06.008","article-title":"Apolipoprotein E structure: insights into function.","volume":"31","author":"DM Hatters","year":"2006","journal-title":"Trends Biochem Sci"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1172\/JCI115288","article-title":"Phenotypes of apolipoprotein B and apolipoprotein E after liver transplantation.","volume":"88","author":"MF Linton","year":"1991","journal-title":"J Clin Invest"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.1016\/S0022-2275(20)42621-5","article-title":"Apolipoprotein E distribution among human plasma lipoproteins: role of the cysteine-arginine interchange at residue 112.","volume":"31","author":"KH Weisgraber","year":"1990","journal-title":"J Lipid Res"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/j.neuron.2009.06.026","article-title":"The role of apolipoprotein E in Alzheimer\u2019s disease.","volume":"63","author":"J Kim","year":"2009","journal-title":"Neuron"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1001\/jama.1997.03550160069041","article-title":"Effects of age, sex, and ethnicity on the association between apolipoprotein E genotype and Alzheimer disease. A meta-analysis. APOE and Alzheimer Disease Meta Analysis Consortium.","volume":"278","author":"LA Farrer","year":"1997","journal-title":"Jama"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1126\/science.8346443","article-title":"Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer\u2019s disease in late onset families.[see comment].","volume":"261","author":"EH Corder","year":"1993","journal-title":"Science"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1001\/archpsyc.61.5.518","article-title":"Apolipoprotein E epsilon4 count affects age at onset of Alzheimer disease, but not lifetime susceptibility: The Cache County Study.","volume":"61","author":"AS Khachaturian","year":"2004","journal-title":"Archives of General Psychiatry"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1038\/ng0694-180","article-title":"Protective effect of apolipoprotein E type 2 allele for late onset Alzheimer disease.","volume":"7","author":"EH Corder","year":"1994","journal-title":"Nature Genetics"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"8718","DOI":"10.1073\/pnas.0803526105","article-title":"Apolipoprotein (apo) E4 enhances HIV-1 cell entry in vitro, and the APOE epsilon4\/epsilon4 genotype accelerates HIV disease progression.","volume":"105","author":"TD Burt","year":"2008","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1089\/neu.2007.0489","article-title":"Meta-analysis of APOE4 allele and outcome after traumatic brain injury.","volume":"25","author":"W Zhou","year":"2008","journal-title":"J Neurotrauma"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1002\/ana.410380219","article-title":"Apolipoprotein E epsilon 4 and cerebral hemorrhage associated with amyloid angiopathy.","volume":"38","author":"SM Greenberg","year":"1995","journal-title":"Ann Neurol"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1067\/mlc.2002.129066","article-title":"Comparative in vivo metabolism of apolipoproteins E2 and E4 in heterozygous apoE2\/4 subjects.","volume":"140","author":"K Ikewaki","year":"2002","journal-title":"J Lab Clin Med"},{"key":"ref14","first-page":"584","article-title":"Type III hyperlipoproteinemia: defective metabolism of an abnormal apolipoprotein E. Science","volume":"211","author":"RE Gregg","year":"1981"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1172\/JCI112645","article-title":"Abnormal in vivo metabolism of apolipoprotein E4 in humans.","volume":"78","author":"RE Gregg","year":"1986","journal-title":"J Clin Invest"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1016\/S0022-2275(20)34460-6","article-title":"Apolipoprotein E metabolism in normolipoproteinemic human subjects.","volume":"25","author":"RE Gregg","year":"1984","journal-title":"J Lipid Res"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.numecd.2005.06.004","article-title":"In-vivo metabolism of VLDL-apolipoprotein-B, -CIII and -E in normolipidemic subjects.","volume":"16","author":"RE Dinkel","year":"2006","journal-title":"Nutr Metab Cardiovasc Dis"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/S0014-4886(03)00088-8","article-title":"APOE epsilon 3\/epsilon 4 heterozygotes have an elevated proportion of apolipoprotein E4 in cerebrospinal fluid relative to plasma, independent of Alzheimer\u2019s disease diagnosis.[see comment].","volume":"183","author":"H Fukumoto","year":"2003","journal-title":"Experimental Neurology"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/1750-1326-2-7","article-title":"Apolipoprotein E levels in cerebrospinal fluid and the effects of ABCA1 polymorphisms.","volume":"2","author":"SE Wahrle","year":"2007","journal-title":"Mol Neurodegener"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/0169-328X(95)00097-C","article-title":"Association of apolipoprotein E genotype with brain levels of apolipoprotein E and apolipoprotein J (clusterin) in Alzheimer disease.","volume":"33","author":"P Bertrand","year":"1995","journal-title":"Brain Research Molecular Brain Research"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1093\/clinchem\/45.4.497","article-title":"Apolipoprotein E in cerebrospinal fluid: relation to phenotype and plasma apolipoprotein E concentrations.","volume":"45","author":"K Yamauchi","year":"1999","journal-title":"Clin Chem"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1006\/nbdi.1996.0023","article-title":"Human apolipoprotein E2, E3, and E4 isoform-specific transgenic mice: human-like pattern of glial and neuronal immunoreactivity in central nervous system not observed in wild-type mice.","volume":"3","author":"PT Xu","year":"1996","journal-title":"Neurobiol Dis"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"89ra57","DOI":"10.1126\/scitranslmed.3002156","article-title":"Human apoE Isoforms Differentially Regulate Brain Amyloid-{beta} Peptide Clearance.","volume":"3","author":"JM Castellano","year":"2011","journal-title":"Sci Transl Med"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"6771","DOI":"10.1523\/JNEUROSCI.0887-09.2009","article-title":"Human APOE isoform-dependent effects on brain beta-amyloid levels in PDAPP transgenic mice.","volume":"29","author":"KR Bales","year":"2009","journal-title":"J Neurosci"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"R15","DOI":"10.1172\/JCI6179","article-title":"Expression of human apolipoprotein E reduces amyloid-beta deposition in a mouse model of Alzheimer\u2019s disease.","volume":"103","author":"DM Holtzman","year":"1999","journal-title":"J Clin Invest"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"2892","DOI":"10.1073\/pnas.050004797","article-title":"Apolipoprotein E isoform-dependent amyloid deposition and neuritic degeneration in a mouse model of Alzheimer\u2019s disease.","volume":"97","author":"DM Holtzman","year":"2000","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1016\/j.neuroscience.2003.10.011","article-title":"Marked regional differences of brain human apolipoprotein E expression in targeted replacement mice.","volume":"124","author":"PM Sullivan","year":"2004","journal-title":"Neuroscience"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"11445","DOI":"10.1523\/JNEUROSCI.1972-08.2008","article-title":"Impact of apolipoprotein E (ApoE) polymorphism on brain ApoE levels.","volume":"28","author":"DR Riddell","year":"2008","journal-title":"J Neurosci"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.ab.2009.07.049","article-title":"Method for the simultaneous quantitation of apolipoprotein E isoforms using tandem mass spectrometry.","volume":"395","author":"KR Wildsmith","year":"2009","journal-title":"Anal Biochem"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1016\/j.jasms.2007.02.009","article-title":"Stable isotope labeling tandem mass spectrometry (SILT) to quantify protein production and clearance rates.","volume":"18","author":"RJ Bateman","year":"2007","journal-title":"J Am Soc Mass Spectrom"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1038\/nm1438","article-title":"Human amyloid-beta synthesis and clearance rates as measured in cerebrospinal fluid in vivo.","volume":"12","author":"RJ Bateman","year":"2006","journal-title":"Nat Med"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1186\/1750-1326-4-21","article-title":"ApoE isoform-dependent changes in hippocampal synaptic function.","volume":"4","author":"KM Korwek","year":"2009","journal-title":"Mol Neurodegener"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1007\/BF00225071","article-title":"Apolipoprotein E (apoE) polymorphism and its influence on ApoE concentrations in the cerebrospinal fluid in Finnish patients with Alzheimer\u2019s disease.","volume":"95","author":"T Lehtimaki","year":"1995","journal-title":"Hum Genet"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/S0014-4886(03)00088-8","article-title":"APOE epsilon 3\/epsilon 4 heterozygotes have an elevated proportion of apolipoprotein E4 in cerebrospinal fluid relative to plasma, independent of Alzheimer\u2019s disease diagnosis.","volume":"183","author":"H Fukumoto","year":"2003","journal-title":"Exp Neurol"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"255","DOI":"10.3233\/JAD-2008-13303","article-title":"Multiple SNPs within and surrounding the apolipoprotein E gene influence cerebrospinal fluid apolipoprotein E protein levels.","volume":"13","author":"LM Bekris","year":"2008","journal-title":"J Alzheimers Dis"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"2429","DOI":"10.1046\/j.1471-4159.1996.66062429.x","article-title":"Brain expression of apolipoproteins E, J, and A-I in Alzheimer\u2019s disease.","volume":"66","author":"SD Harr","year":"1996","journal-title":"J Neurochem"},{"key":"ref37","first-page":"12623","article-title":"Seeding of A beta fibril formation is inhibited by all three isotypes of apolipoprotein E. Biochemistry","volume":"35","author":"SJ Wood","year":"1996"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/S0006-8993(99)01894-6","article-title":"Apolipoprotein E and beta-amyloid levels in the hippocampus and frontal cortex of Alzheimer\u2019s disease subjects are disease-related and apolipoprotein E genotype dependent.","volume":"843","author":"U Beffert","year":"1999","journal-title":"Brain Res"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"17972","DOI":"10.1074\/jbc.272.29.17972","article-title":"Targeted replacement of the mouse apolipoprotein E gene with the common human APOE3 allele enhances diet-induced hypercholesterolemia and atherosclerosis.","volume":"272","author":"PM Sullivan","year":"1997","journal-title":"J Biol Chem"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"2803","DOI":"10.1523\/JNEUROSCI.5170-04.2005","article-title":"Human apolipoprotein E4 alters the amyloid-beta 40:42 ratio and promotes the formation of cerebral amyloid angiopathy in an amyloid precursor protein transgenic model.","volume":"25","author":"JD Fryer","year":"2005","journal-title":"J Neurosci"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"10658","DOI":"10.1523\/JNEUROSCI.1922-05.2005","article-title":"Effect of domain interaction on apolipoprotein E levels in mouse brain.","volume":"25","author":"G Ramaswamy","year":"2005","journal-title":"J Neurosci"},{"key":"ref42","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1007\/BF01790099","article-title":"Apolipoprotein E polymorphism in The Netherlands and its effect on plasma lipid and apolipoprotein levels.","volume":"80","author":"M Smit","year":"1988","journal-title":"Hum Genet"},{"key":"ref43","doi-asserted-by":"crossref","first-page":"e176","DOI":"10.1371\/journal.pmed.0030176","article-title":"ApoE plasma levels and risk of cardiovascular mortality in old age.","volume":"3","author":"SP Mooijaart","year":"2006","journal-title":"PLoS Med"},{"key":"ref44","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1002\/1531-8249(200008)48:2<201::AID-ANA10>3.0.CO;2-X","article-title":"Differences in the Abeta40\/Abeta42 ratio associated with cerebrospinal fluid lipoproteins as a function of apolipoprotein E genotype.","volume":"48","author":"AM Fagan","year":"2000","journal-title":"Ann Neurol"},{"key":"ref45","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/S0014-4886(03)00185-7","article-title":"Differential metabolism of ApoE isoforms in plasma and CSF.","volume":"183","author":"SE Wahrle","year":"2003","journal-title":"Exp Neurol"},{"key":"ref46","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1161\/01.ATV.20.5.1309","article-title":"In vivo metabolism of ApoB, ApoA-I, and VLDL triglycerides in a form of hypobetalipoproteinemia not linked to the ApoB gene.","volume":"20","author":"N Elias","year":"2000","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"ref47","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1016\/S0026-0495(98)90345-6","article-title":"Proposal of a multicompartmental model for use in the study of apolipoprotein E metabolism.","volume":"47","author":"JS Millar","year":"1998","journal-title":"Metabolism"},{"key":"ref48","doi-asserted-by":"crossref","first-page":"2738","DOI":"10.1194\/jlr.M600302-JLR200","article-title":"Studying apolipoprotein turnover with stable isotope tracers: correct analysis is by modeling enrichments.","volume":"47","author":"R Ramakrishnan","year":"2006","journal-title":"J Lipid Res"},{"key":"ref49","article-title":"Cerebrospinal fluid in diseases of the nervous system.","author":"RA Fishman","year":"1992"},{"key":"ref50","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1038\/nm.2496","article-title":"Reply to: Fractional synthesis and clearance rates for amyloid [beta].","volume":"17","author":"DL Elbert","year":"2011","journal-title":"Nat Med"},{"key":"ref51","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.nbd.2004.11.005","article-title":"Production and characterization of astrocyte-derived human apolipoprotein E isoforms from immortalized astrocytes and their interactions with amyloid-beta.","volume":"19","author":"M Morikawa","year":"2005","journal-title":"Neurobiol Dis"},{"key":"ref52","doi-asserted-by":"crossref","first-page":"1432","DOI":"10.1016\/S0140-6736(94)92557-7","article-title":"Protection against Alzheimer\u2019s disease with apoE epsilon 2.","volume":"343","author":"C Talbot","year":"1994","journal-title":"Lancet"},{"key":"ref53","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1016\/S0022-2275(20)38434-0","article-title":"Heterogeneity of apolipoprotein E epitope expression on human lipoproteins: importance for apolipoprotein E function.","volume":"29","author":"ES Krul","year":"1988","journal-title":"J Lipid Res"},{"key":"ref54","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1002\/bms.1200211004","article-title":"Measurement of muscle protein fractional synthetic rate by capillary gas chromatography\/combustion isotope ratio mass spectrometry.","volume":"21","author":"KE Yarasheski","year":"1992","journal-title":"Biol Mass Spectrom"},{"key":"ref55","article-title":"Isotope tracers in metabolic research : principles and practice of kinetic analysis.","author":"RR Wolfe","year":"2005"},{"key":"ref56","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1053\/j.gastro.2007.11.038","article-title":"Alterations in adipose tissue and hepatic lipid kinetics in obese men and women with nonalcoholic fatty liver disease.","volume":"134","author":"E Fabbrini","year":"2008","journal-title":"Gastroenterology"}],"updated-by":[{"DOI":"10.1371\/annotation\/9bd329b7-cdea-45ec-a4aa-a173855dc0b9","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2012,7,3]],"date-time":"2012-07-03T00:00:00Z","timestamp":1341273600000}}],"container-title":["PLoS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0038013","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,1,16]],"date-time":"2022-01-16T17:53:27Z","timestamp":1642355607000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0038013"}},"subtitle":[],"editor":[{"given":"Steven","family":"Estus","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2012,6,4]]},"references-count":56,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2012,6,4]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0038013","relation":{"correction":[{"id-type":"doi","id":"10.1371\/annotation\/9bd329b7-cdea-45ec-a4aa-a173855dc0b9","asserted-by":"object"}]},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,6,4]]}}}